𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paracrine Cytokine Adjuvants in Cancer Immunotherapy

✍ Scribed by Pardoll, D M

Book ID
111873125
Publisher
Annual Reviews
Year
1995
Tongue
English
Weight
547 KB
Volume
13
Category
Article
ISSN
0732-0582

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of cellular and cytokine adjuvants i
Use of cellular and cytokine adjuvants in the immunotherapy of cancer
✍ Salgaller, Michael L.; Lodge, Patricia A. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Cellular and cytokine adjuvants, often immune effector cells and soluble factors, respectively, are supplemental and/or follow-up treatments of human origin for cancer patients who have unsatisfactory clinical responses to conventional chemotherapy, radiotherapy, and surgery. Since many human studie

Cytokines in cancer immunity and immunot
Cytokines in cancer immunity and immunotherapy
✍ Mark J. Smyth; Erika Cretney; Michael H. Kershaw; Yoshihiro Hayakawa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 288 KB
Levamisole as adjuvant immunotherapy in
Levamisole as adjuvant immunotherapy in breast cancer
✍ Annette D. Treurniet-Donker; Marlies L. Meischke-De Jongh; Wim L. J. Van Putten πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 350 KB πŸ‘ 2 views
Surgical adjuvant immunotherapy for colo
Surgical adjuvant immunotherapy for colorectal cancer
✍ Warren E. Enker; Janet L. Jacobitz; Karen Craft; Robert W. Wissler πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 550 KB

## Abstract One hundred forty‐four Wistar‐Furth rats in 12 therapeutic groups have been studied in a long‐term comparison of the effectiveness of nonspecific immunotherapy with MER (methanol extraction residue) vs active‐specific immunotherapy with neuraminidase‐modified tumor cells. Six months aft